Accueil>>Lipids>> Sterol Lipids>>Mometasone

Mometasone (Synonyms: (+)-Mometasone)

Catalog No.GC47698

La mométasone est un glucocorticoÏde inhalé.

Products are for research use only. Not for human use. We do not sell to patients.

Mometasone Chemical Structure

Cas No.: 105102-22-5

Taille Prix Stock Qté
500 μg
53,00 $US
En stock
1 mg
101,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Mometasone is a synthetic glucocorticoid with anti-inflammatory and anti-allergic activities.1,2,3 In vivo, mometasone (3 mg/kg) reduces pulmonary edema and neutrophil infiltration in a mouse model of chlorine-induced chemical lung injury.1 Intranasal administration of mometasone (0.2 µg/animal) reduces nose-rubbing behavior, sneezing, and nasal mucosal levels of IL-4 in a mouse model of allergic rhinitis.2 Mometasone also reduces nasal mucosal epithelial destruction, fibrosis, and cilia loss in a rat model of rhinitis medicamentosa induced by oxymetazoline .

1.Kitlevsen, D.K., Povlsen, G.K., Berezin, V., et al.NCAM-induced intracellular signaling revisitedJ. Neurosci. Res.86(4)727-743(2008) 2.Williams, E.J., Furness, J., Walsh, F.S., et al.Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherinNeuron.13(3)583-594(1994) 3.Van Acker, H.H., Van Acker, Z.P., Versteven, M., et al.CD56 homodimerization and participation in anti-tumor immune effector cell functioning: A role for interleukin-15Cancers (Basel)11(7)1029(2019)

Avis

Review for Mometasone

Average Rating: 5 ★★★★★ (Based on Reviews and 11 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Mometasone

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.